ترقية الحساب

🌟 Découvrez toutes nos offres sur desktop ou tablette !

Equine Veterinary Pharmaceuticals Market Expected to Reach USD 2.93 Billion by 2031 as Preventive Care and Performance Drug Use Expand Across Competitive Equine Sectors

[Lexington, KY – May 19th, 2025] – According to Clearview Market Insights, the global Equine Veterinary Pharmaceuticals Market, currently valued at USD 1.8 billion, is projected to reach USD 2.93 billion by 2031, expanding at a CAGR of 7.2%. This growth is driven by increased veterinary intervention in sports horses, rising demand for geriatric care, and enhanced compliance tools for drug delivery.

Request Sample @ https://clearviewmarketinsights.com/report-details/equine-veterinary-pharmaceuticals-market/

2024 Industry Milestones

Racehorse Therapy Innovation

  • Dechra launches once-a-month injectable NSAID for chronic joint pain.
  • Zoetis releases an oral anti-ulcer gel with zero-day withdrawal for show horses.

Digital Vet Solutions Integrated with Pharmacies

  • North America sees rise in tele-vet platforms linked to automated prescription refills.

Regulatory Updates Improve Transparency

  • FEI and U.S. Racing authorities enforce new digital drug logging systems.
  • Japan Racing Association approves two new anti-inflammatory drugs.

Executive Insights

"Horses are elite athletes with complex needs. Precision pharma, fast-acting relief, and strict compliance are redefining how veterinary care is delivered," said Dr. Alan Crowe, Senior Equine Pharmacology Analyst at Clearview Market Insights.

"The future lies in long-acting therapies, companion apps for monitoring, and zero-residue medications that don't compromise sport integrity," added Samantha Yuen, Global Equine Strategy Director, Zoetis.

Roadmap to 2031

  • 2025: First AI-powered dosing system integrated with wearables
  • 2026: Fully FEI-compliant, race-safe anti-inflammatory portfolios become standard
  • 2028: 40% of equine medications delivered via sustained-release or transdermal methods
  • 2030: Personalized pharmaceutical plans based on genetics and digital health history
  • 2031: AI-informed vet-pharma cloud platforms manage 70% of prescriptions globally

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Babafig 🌍 https://www.babafig.com